← Back to Search

Sleep Interventions for Alcohol Use (MoRA Trial)

N/A
Recruiting
Led By Melynda D Casement, PhD
Research Sponsored by University of Oregon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights

MoRA Trial Summary

This trial aims to understand how stress, sleep, and alcohol interact in young adults, to inform preventative interventions for alcohol use disorders. #health #prevention

Who is the study for?
This trial is for English-speaking young adults aged 18-24 who engage in high-risk drinking as defined by NIAAA and have specific sleep patterns. They must have experienced moderate stress in their lifetime but can't participate if they've recently traveled across time zones, changed medications, or are at risk of suicide.Check my eligibility
What is being tested?
The study investigates how life stress and sleep habits (both duration and timing) relate to alcohol use in young adults. It aims to understand these connections better to eventually help prevent alcohol use disorders.See study design
What are the potential side effects?
Since the interventions involve changes in sleep patterns rather than medication, typical drug side effects aren't expected. However, altering one's sleep schedule could potentially lead to temporary fatigue or mood changes.

MoRA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol use
Reward-related brain function
Stress-related brain function

MoRA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Sleep extension and advance "Lark Routine"Experimental Treatment1 Intervention
Participants go to bed 90 minutes earlier than their typical average bedtime to extend sleep duration and advance sleep timing
Group II: Regular sleep duration and timing "Owl Routine"Active Control1 Intervention
Participants go to bed at their typical average bedtime

Find a Location

Who is running the clinical trial?

University of PittsburghOTHER
1,722 Previous Clinical Trials
16,342,846 Total Patients Enrolled
13 Trials studying Alcoholism
2,059 Patients Enrolled for Alcoholism
University of OregonLead Sponsor
80 Previous Clinical Trials
46,816 Total Patients Enrolled
1 Trials studying Alcoholism
456 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
801 Previous Clinical Trials
1,365,307 Total Patients Enrolled
423 Trials studying Alcoholism
985,618 Patients Enrolled for Alcoholism

Media Library

Sleep extension and advance "Lark Routine" Clinical Trial Eligibility Overview. Trial Name: NCT05684094 — N/A
Alcoholism Research Study Groups: Regular sleep duration and timing "Owl Routine", Sleep extension and advance "Lark Routine"
Alcoholism Clinical Trial 2023: Sleep extension and advance "Lark Routine" Highlights & Side Effects. Trial Name: NCT05684094 — N/A
Sleep extension and advance "Lark Routine" 2023 Treatment Timeline for Medical Study. Trial Name: NCT05684094 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment accept participants who have surpassed the age of majority?

"Those that meet the age requirement for this clinical trial, which is greater than 18 years but not exceeding 24 years old, are welcome to participate."

Answered by AI

Is participation in this experiment available to me?

"This medical trial is searching for 90 patients between 18 and 24 years old who suffer from alcoholism. To be accepted, these conditions must all be met."

Answered by AI

Are there opportunities for volunteers with this experiment?

"Data hosted on clinicaltrials.gov suggest that, as of now, this particular medical trial is not admitting new patients. The experiment was first listed back in April 15th 2023 and last modified 4 days later; however, there are 380 other trials actively enrolling participants at the moment."

Answered by AI
~60 spots leftby Feb 2027